Track topics on Twitter Track topics that are important to you
Eylea net product sales totaled $854 million in the United States for the first quarter, up 9% over the same quarter last year, according to a Regeneron press release.In the first quarter of 2016, Eylea (aflibercept) injection sales totaled $781 million.
Original Article: Eylea sales up in first quarterNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...